These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

238 related articles for article (PubMed ID: 26341317)

  • 41. Homogenous generation of dopaminergic neurons from multiple hiPSC lines by transient expression of transcription factors.
    Mahajani S; Raina A; Fokken C; Kügler S; Bähr M
    Cell Death Dis; 2019 Nov; 10(12):898. PubMed ID: 31776327
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Morphological and behavioral impact of AAV2/5-mediated overexpression of human wildtype alpha-synuclein in the rat nigrostriatal system.
    Gombash SE; Manfredsson FP; Kemp CJ; Kuhn NC; Fleming SM; Egan AE; Grant LM; Ciucci MR; MacKeigan JP; Sortwell CE
    PLoS One; 2013; 8(11):e81426. PubMed ID: 24312298
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Associated degeneration of ventral tegmental area dopaminergic neurons in the rat nigrostriatal lactacystin model of parkinsonism and their neuroprotection by valproate.
    Harrison IF; Anis HK; Dexter DT
    Neurosci Lett; 2016 Feb; 614():16-23. PubMed ID: 26742637
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Novel AAV-based rat model of forebrain synucleinopathy shows extensive pathologies and progressive loss of cholinergic interneurons.
    Aldrin-Kirk P; Davidsson M; Holmqvist S; Li JY; Björklund T
    PLoS One; 2014; 9(7):e100869. PubMed ID: 24999658
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model.
    Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M
    Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
    Buck K; Landeck N; Ulusoy A; Majbour NK; El-Agnaf OM; Kirik D
    Neurobiol Dis; 2015 Jun; 78():100-14. PubMed ID: 25818009
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Chronic α-Synuclein Accumulation in Rat Hippocampus Induces Lewy Bodies Formation and Specific Cognitive Impairments.
    Kasongo DW; de Leo G; Vicario N; Leanza G; Legname G
    eNeuro; 2020; 7(3):. PubMed ID: 32393581
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Overexpression of alpha-synuclein in rat substantia nigra results in loss of dopaminergic neurons, phosphorylation of alpha-synuclein and activation of caspase-9: resemblance to pathogenetic changes in Parkinson's disease.
    Yamada M; Iwatsubo T; Mizuno Y; Mochizuki H
    J Neurochem; 2004 Oct; 91(2):451-61. PubMed ID: 15447678
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Nigrostriatal overabundance of α-synuclein leads to decreased vesicle density and deficits in dopamine release that correlate with reduced motor activity.
    Gaugler MN; Genc O; Bobela W; Mohanna S; Ardah MT; El-Agnaf OM; Cantoni M; Bensadoun JC; Schneggenburger R; Knott GW; Aebischer P; Schneider BL
    Acta Neuropathol; 2012 May; 123(5):653-69. PubMed ID: 22361813
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.
    Guatteo E; Rizzo FR; Federici M; Cordella A; Ledonne A; Latini L; Nobili A; Viscomi MT; Biamonte F; Landrock KK; Martini A; Aversa D; Schepisi C; D'Amelio M; Berretta N; Mercuri NB
    Exp Neurol; 2017 Jan; 287(Pt 1):21-33. PubMed ID: 27771352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Apomorphine-evoked redistribution of neurokinin-3 receptors in dopaminergic dendrites and neuronal nuclei of the rat ventral tegmental area.
    Misono K; Lessard A
    Neuroscience; 2012 Feb; 203():27-38. PubMed ID: 22200547
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of ST1936, a selective serotonin-6 agonist, on electrical activity of putative mesencephalic dopaminergic neurons in the rat brain.
    Borsini F; Bordi F; Poggi A; Di Matteo V
    J Psychopharmacol; 2015 Jul; 29(7):802-11. PubMed ID: 25735994
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term RNAi knockdown of α-synuclein in the adult rat substantia nigra without neurodegeneration.
    Zharikov A; Bai Q; De Miranda BR; Van Laar A; Greenamyre JT; Burton EA
    Neurobiol Dis; 2019 May; 125():146-153. PubMed ID: 30658149
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Comparison of the behavioural and histological characteristics of the 6-OHDA and α-synuclein rat models of Parkinson's disease.
    Decressac M; Mattsson B; Björklund A
    Exp Neurol; 2012 May; 235(1):306-15. PubMed ID: 22394547
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Differential contribution of Ih to the integration of excitatory synaptic inputs in substantia nigra pars compacta and ventral tegmental area dopaminergic neurons.
    Masi A; Narducci R; Resta F; Carbone C; Kobayashi K; Mannaioni G
    Eur J Neurosci; 2015 Nov; 42(9):2699-706. PubMed ID: 26354486
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Loss of dopaminergic nigrostriatal neurons accounts for the motivational and affective deficits in Parkinson's disease.
    Drui G; Carnicella S; Carcenac C; Favier M; Bertrand A; Boulet S; Savasta M
    Mol Psychiatry; 2014 Mar; 19(3):358-67. PubMed ID: 23399912
    [TBL] [Abstract][Full Text] [Related]  

  • 57. AAV.shRNA-mediated downregulation of ROCK2 attenuates degeneration of dopaminergic neurons in toxin-induced models of Parkinson's disease in vitro and in vivo.
    Saal KA; Koch JC; Tatenhorst L; Szegő EM; Ribas VT; Michel U; Bähr M; Tönges L; Lingor P
    Neurobiol Dis; 2015 Jan; 73():150-62. PubMed ID: 25283984
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Ser129D mutant alpha-synuclein induces earlier motor dysfunction while S129A results in distinctive pathology in a rat model of Parkinson's disease.
    Febbraro F; Sahin G; Farran A; Soares S; Jensen PH; Kirik D; Romero-Ramos M
    Neurobiol Dis; 2013 Aug; 56():47-58. PubMed ID: 23567651
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Generation of a alpha-synuclein-based rat model of Parkinson's disease.
    Recchia A; Rota D; Debetto P; Peroni D; Guidolin D; Negro A; Skaper SD; Giusti P
    Neurobiol Dis; 2008 Apr; 30(1):8-18. PubMed ID: 18313315
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lesions of dopaminergic neurons in the substantia nigra pars compacta and in the ventral tegmental area enhance depressive-like behavior in rats.
    Winter C; von Rumohr A; Mundt A; Petrus D; Klein J; Lee T; Morgenstern R; Kupsch A; Juckel G
    Behav Brain Res; 2007 Dec; 184(2):133-41. PubMed ID: 17698212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.